Related Experiment Video
Updated: Nov 26, 2025

06:39
High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
3.3K
Chasing COVID-19 through SARS-CoV-2 spike glycoprotein.
Shailendra K Saxena1, Swatantra Kumar1, Preeti Baxi2
1Centre for Advanced Research (CFAR), Faculty of Medicine, King George's Medical University (KGMU), Lucknow, 226003 India.
Virusdisease
|December 14, 2020
Summary
The Spike glycoprotein (S-glycoprotein) of SARS-CoV-2 was modeled, revealing structural differences from SARS-CoV. This analysis aids in developing vaccines and therapeutics for COVID-19.
Area of Science:
- Virology
- Structural Biology
- Immunology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has had a global impact.
- The Spike glycoprotein (S-glycoprotein) is essential for SARS-CoV-2 infectivity.
- Understanding S-glycoprotein structure is key to combating the virus.

